What are the recommended antibiotics for Campylobacter (C.) jejuni causing severe diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Campylobacter Jejuni Causing Severe Diarrhea

Azithromycin is the preferred first-line antibiotic for treating severe diarrhea caused by Campylobacter jejuni, with a recommended dose of 1000 mg as a single dose or 500 mg daily for 3 days. 1, 2

First-Line Treatment Options

Azithromycin

  • Dosage: 1000 mg as a single dose or 500 mg daily for 3 days 1
  • Rationale:
    • Preferred for severe Campylobacter infections due to high fluoroquinolone resistance rates 1
    • All Campylobacter isolates in multiple studies showed susceptibility to azithromycin 3, 4
    • Superior to ciprofloxacin in decreasing Campylobacter excretion 3
    • Achieves high intracellular concentrations effective against resistant strains 5

Alternative Options (if azithromycin is unavailable or contraindicated)

Fluoroquinolones

  • Only if local resistance patterns confirm susceptibility 5
  • Ciprofloxacin: 750 mg as a single dose or 500 mg twice daily for 3 days 1
  • Levofloxacin: 500 mg once daily for 3 days 1, 2
  • Important caveat: High fluoroquinolone resistance rates (58-100%) have been reported in many regions, particularly Southeast Asia 3, 4, 6

Clinical Considerations

Resistance Patterns

  • Fluoroquinolone resistance is prevalent in Campylobacter (up to 58% for C. jejuni and 100% for C. coli in some regions) 4, 6
  • Erythromycin/azithromycin resistance remains low, with most studies showing 100% susceptibility 4, 6
  • Consider local resistance patterns when selecting therapy

Treatment Algorithm

  1. First-line: Azithromycin 1000 mg single dose or 500 mg daily for 3 days
  2. If azithromycin unavailable: Fluoroquinolone (only if local resistance patterns confirm susceptibility)
  3. For severe cases with systemic symptoms: Consider adding supportive care with IV fluids and electrolyte replacement

Special Populations

  • Immunocompromised patients: Lower threshold for antibiotic treatment with azithromycin 5
  • Pediatric patients: Azithromycin 30 mg/kg as a single dose 5

Supportive Therapy

Fluid Replacement

  • Oral rehydration with reduced osmolarity solution is recommended 5
  • IV fluids may be necessary in severe cases with significant dehydration

Symptomatic Relief

  • Loperamide: May be combined with antibiotics (4 mg first dose, then 2 mg after each loose stool, not exceeding 16 mg in 24 hours) 1
  • Caution: Avoid loperamide in patients with dysentery or high fever 1

Monitoring and Follow-up

  • Monitor for resolution of bloody diarrhea within 48-72 hours 5
  • Watch for worsening symptoms, increased abdominal pain, fever, and dehydration 5
  • Consider C. difficile testing if symptoms persist despite appropriate therapy 5

Important Caveats

  • Campylobacter infection has been associated with subsequent occurrence of Guillain–Barré syndrome 1
  • Abdominal pain tends to be particularly severe in Campylobacter enteritis and may mimic appendicitis 1
  • Early treatment (within 72 hours of symptom onset) is most effective 5
  • Prolonged antibiotic courses should be avoided without clear indication 5
  • Rifaximin should NOT be used for Campylobacter infections as it is ineffective for invasive pathogens 1, 2

By following these evidence-based recommendations, clinicians can effectively manage severe diarrhea caused by Campylobacter jejuni while minimizing the risk of treatment failure due to antimicrobial resistance.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Guideline

Management of Recurrent EPEC E. coli Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.